ෆයිසර් ගහමුතේ

[riduna pm]

 

[helplesser]

Lol. Apith gahuwa hora paren.

 

[HKavinda]

පිට ගැස්මට දෙන එන්නතත් ඒ එක්කම ගහනවද

 

[tharakaf]

Lol. Apith gahuwa hora paren.

Ehenam puka dennada ban ara karalak hoya hoya hitiye huththo?

 

[kinkon]

ඔය දොස්තර වෙන තැනකට මාරු කරා

 

[ThimalM™]

Sinopharm gahapu kenekta pfizer gahuwoth aulak weida ?

 

[harshana-lk]

Sinopharm gahapu kenekta pfizer gahuwoth aulak weida ?

aurudak yanakan ba vaccine 2 jathi 2kak

 

[Hyaenidae]

aurudak yanakan ba vaccine 2 jathi 2kak

koheda ehema thibbe

https://www.bloomberg.com/news/arti...booster-doses-mandatory-for-sinopharm-vaccine

 

[riduna pm]

කැන්ඩි වලත් ආතල් එකක් දීලා කියලා ආරංචී
ස්පුට්නික් පවුලේ උන්ට ගහලා මිනිස්සු හරවලා යවලා

 

[RandomGuy]

දූපත් ආතල් තමයි..

වෙන රටවල එවුන්ට නම් ඕව කලට වෙලාවට හම්බවෙන නිසා උන් ඕවට එක එක conspiracy තියරි හදාගෙන දඟලනවා.
ලංකාවේ එවුන් වැටෙන් පැනල ගිහින් හොරෙන් ගහගෙනත් එනවා.

 

[hodakolla]

BUMPER

 

[sam_sajith]

koheda ehema thibbe

https://www.bloomberg.com/news/arti...booster-doses-mandatory-for-sinopharm-vaccine

https://www.reuters.com/business/he...st-mixing-matching-covid-vaccines-2021-07-12/

WHO warns individuals against mixing and matching COVID vaccines​

GENEVA, July 13 (Reuters) - The World Health Organization's chief scientist has advised individualsagainst mixing and matching COVID-19 vaccines from different manufacturers, saying such decisions should be left to public health authorities.

"It's a little bit of a dangerous trend here," Soumya Swaminathan told an online briefing on Monday after a question about booster shots. "It will be a chaotic situation in countries if citizens start deciding when and who will be taking a second, a third and a fourth dose."

Swaminathan had called mixing a "data-free zone" but later clarified her remarks in an overnight tweet.

"Individuals should not decide for themselves, public health agencies can, based on available data," she said in the tweet. "Data from mix and match studies of different vaccines are awaited - immunogenicity and safety both need to be evaluated."


The WHO's Strategic Advisory Group of Experts on vaccines said in June the Pfizer Inc (PFE.N) vaccine could be used as a second dose after an initial dose of AstraZeneca (AZN.L), if the latter is not available.

A clinical trial led by the University of Oxford in the UK is ongoing to investigate mixing the regimen of AstraZeneca and Pfizer vaccines. The trial was recently expanded to include the Moderna Inc (MRNA.O) and Novavax Inc (NVAX.O) vaccines.